ARROWHEAD PHARMACEUTICALS, INC. Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain of $1.07 million as of 2021-12-31, per its 10-Q filed 2022-02-02.
Discontinued › Notes › Investments › Debt and Equity Securities › Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain · last filed 2022-02-02
- 2021-12-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $1.07M.
- 2021-09-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $1.95M.
- 2021-06-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $2.71M.
- 2021-03-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $3.54M.
| Period end | Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain as first filed |
|---|---|---|
| 2021-12-31 | $1.07M 10-Q · filed 2022-02-02 | |
| 2021-09-30 | $1.95M 10-Q · filed 2022-02-02 | |
| 2021-06-30 | $2.71M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $3.54M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $4.84M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $6.16M 10-K · filed 2021-11-22 | $6.16M 10-K · filed 2020-11-23 |
| 2020-06-30 | $7.03M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $2.00M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $989.00K 10-Q · filed 2020-02-05 | |
| 2019-09-30 | $1.10M 10-K · filed 2020-11-23 | |
| 2019-06-30 | $1.15M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $755.66K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $228.82K 10-Q · filed 2019-02-07 | |
| 2015-03-31 | $784.00 10-Q · filed 2015-05-11 | |
| 2013-09-30 | $7.50K 10-K · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |